| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2025 ( Subtotal = $0 ) |
| | 2025 | 2022 | TYMORA ANALYTICAL OPERATIONS LLC | 1201 CUMBERLAND AVE | WEST LAFAYETTE | IN | 47906-1359 | TIPPECANOE | USA | R43CA272045 | Development of lavage EV protein biomarkers for minimally-invasive detection of endometrial cancer | 000 | 1 | NIH | 1/8/2025 | $0 |
|
| Issue Date FY: 2024 ( Subtotal = $815,028 ) |
| | 2024 | 2024 | TYMORA ANALYTICAL OPERATIONS LLC | 1201 CUMBERLAND AVE | WEST LAFAYETTE | IN | 47906-1359 | TIPPECANOE | USA | R44AG063589 | Validation and clinicaldevelopment of plasma EV protein biomarkers for minimally-invasive detection of Alzheimersdisease | 000 | 2 | NIH | 9/20/2024 | $815,028 |
| | 2024 | 2021 | TYMORA ANALYTICAL OPERATIONS LLC | 1201 CUMBERLAND AVE | WEST LAFAYETTE | IN | 47906-1359 | TIPPECANOE | USA | R44CA239845 | Development of non-invasive biomarker discovery and diagnostics approach for bladder cancer based on urine proteome and phosphoproteome | 000 | 3 | NIH | 2/12/2024 | $0 |
| | 2024 | 2021 | TYMORA ANALYTICAL OPERATIONS LLC | 1201 CUMBERLAND AVE | WEST LAFAYETTE | IN | 47906-1359 | TIPPECANOE | USA | R43CA261305 | Development of companion diagnostics for dasatinib-based personalized therapy for T-ALL | 000 | 1 | NIH | 3/4/2024 | $0 |
|
| Issue Date FY: 2023 ( Subtotal = $0 ) |
| | 2023 | 2020 | TYMORA ANALYTICAL OPERATIONS LLC | 1201 CUMBERLAND AVE | WEST LAFAYETTE | IN | 47906-1359 | TIPPECANOE | USA | R41GM136093 | Developing high throughput measurement of thiopurine in DNA by mass spectrometry | 000 | 1 | NIH | 9/25/2023 | $0 |
|
| Issue Date FY: 2022 ( Subtotal = $290,000 ) |
| | 2022 | 2022 | TYMORA ANALYTICAL OPERATIONS, LLC | 1201 CUMBERLAND AVE STE 209 | WEST LAFAYETTE | IN | 47906-1359 | TIPPECANOE | USA | R43CA272045 | Development of lavage EV protein biomarkers for minimally-invasive detection of endometrial cancer | 000 | 1 | NIH | 8/19/2022 | $290,000 |
| | 2022 | 2020 | TYMORA ANALYTICAL OPERATIONS, LLC | 1201 CUMBERLAND AVE STE 209 | WEST LAFAYETTE | IN | 47906-1359 | TIPPECANOE | USA | R41GM136093 | Developing high throughput measurement of thiopurine in DNA by mass spectrometry | 000 | 1 | NIH | 1/27/2022 | $0 |
| | 2022 | 2020 | TYMORA ANALYTICAL OPERATIONS, LLC | 1201 CUMBERLAND AVE STE 209 | WEST LAFAYETTE | IN | 47906-1359 | TIPPECANOE | USA | R41AG066328 | Developing EV surface proteins as biosignatures for Alzheimer's disease (AD) | 000 | 1 | NIH | 6/21/2022 | $0 |
|
| Issue Date FY: 2021 ( Subtotal = $1,010,000 ) |
| | 2021 | 2021 | TYMORA ANALYTICAL OPERATIONS, LLC | 1201 CUMBERLAND AVE STE 209 | WEST LAFAYETTE | IN | 47906-1359 | TIPPECANOE | USA | R43CA261305 | Development of companion diagnostics for dasatinib-based personalized therapy for T-ALL | 000 | 1 | NIH | 8/2/2021 | $310,000 |
| | 2021 | 2021 | TYMORA ANALYTICAL OPERATIONS, LLC | 1201 CUMBERLAND AVE STE 209 | WEST LAFAYETTE | IN | 47906-1359 | TIPPECANOE | USA | R44CA239845 | Development of non-invasive biomarker discovery and diagnostics approach for bladder cancer based on urine proteome and phosphoproteome | 001 | 3 | NIH | 8/11/2021 | $700,000 |
| | 2021 | 2019 | TYMORA ANALYTICAL OPERATIONS, LLC | 1201 CUMBERLAND AVE STE 209 | WEST LAFAYETTE | IN | 47906-1359 | TIPPECANOE | USA | R43AG063589 | Development of non-invasive research and diagnostics platform for Alzheimer's disease based on plasma exosomes | 000 | 1 | NIH | 3/12/2021 | $0 |
| | 2021 | 2019 | TYMORA ANALYTICAL OPERATIONS, LLC | 1201 CUMBERLAND AVE STE 209 | WEST LAFAYETTE | IN | 47906-1359 | TIPPECANOE | USA | R44CA239845 | Development of non-invasive biomarker discovery and diagnostics approach for bladder cancer based on urine proteome and phosphoproteome | 000 | 1 | NIH | 10/23/2020 | $0 |
|
| Issue Date FY: 2020 ( Subtotal = $1,144,884 ) |
| | 2020 | 2020 | TYMORA ANALYTICAL OPERATIONS, LLC | 1201 CUMBERLAND AVE STE 209 | WEST LAFAYETTE | IN | 47906-1359 | TIPPECANOE | USA | R41GM136093 | Developing high throughput measurement of thiopurine in DNA by mass spectrometry | 000 | 1 | NIH | 4/2/2020 | $299,975 |
| | 2020 | 2020 | TYMORA ANALYTICAL OPERATIONS, LLC | 1201 CUMBERLAND AVE STE 209 | WEST LAFAYETTE | IN | 47906-1359 | TIPPECANOE | USA | R41AG066328 | Developing EV surface proteins as biosignatures for Alzheimer's disease (AD) | 000 | 1 | NIH | 3/11/2020 | $244,909 |
| | 2020 | 2020 | TYMORA ANALYTICAL OPERATIONS, LLC | 1201 CUMBERLAND AVE STE 209 | WEST LAFAYETTE | IN | 47906-1359 | TIPPECANOE | USA | R44CA239845 | Development of non-invasive biomarker discovery and diagnostics approach for bladder cancer based on urine proteome and phosphoproteome | 000 | 2 | NIH | 9/14/2020 | $600,000 |
| | 2020 | 2016 | TYMORA ANALYTICAL OPERATIONS, LLC | 1201 CUMBERLAND AVE STE 209 | WEST LAFAYETTE | IN | 47906-1359 | TIPPECANOE | USA | R41CA210772 | Developing novel RPPA for the detection of metastatic prostate cancer | 000 | 1 | NIH | 1/19/2020 | $0 |
|
| Issue Date FY: 2019 ( Subtotal = $440,368 ) |
| | 2019 | 2019 | TYMORA ANALYTICAL OPERATIONS, LLC | 1201 CUMBERLAND AVE STE 209 | WEST LAFAYETTE | IN | 47906-1359 | TIPPECANOE | USA | R43AG063589 | Development of non-invasive research and diagnostics platform for Alzheimer's disease based on plasma exosomes | 000 | 1 | NIH | 6/13/2019 | $215,369 |
| | 2019 | 2019 | TYMORA ANALYTICAL OPERATIONS, LLC | 1201 CUMBERLAND AVE STE 209 | WEST LAFAYETTE | IN | 47906-1359 | TIPPECANOE | USA | R44CA239845 | Development of non-invasive biomarker discovery and diagnostics approach for bladder cancer based on urine proteome and phosphoproteome | 000 | 1 | NIH | 8/30/2019 | $224,999 |
| | 2019 | 2016 | TYMORA ANALYTICAL OPERATIONS, LLC | 1201 CUMBERLAND AVE STE 209 | WEST LAFAYETTE | IN | 47906-1359 | TIPPECANOE | USA | R44CA200040 | Multiplexed detection and imaging of protein phosphorylation based on soluble nanopolymers | 000 | 3 | NIH | 8/28/2019 | $0 |
|
| Issue Date FY: 2018 ( Subtotal = $2,000 ) |
| | 2018 | 2018 | TYMORA ANALYTICAL OPERATIONS, LLC | 3495 KENT AVE STE E400 | WEST LAFAYETTE | IN | 47906-1074 | TIPPECANOE | USA | R41CA210772 | Developing novel RPPA for the detection of metastatic prostate cancer | 001 | 1 | NIH | 9/14/2018 | $2,000 |
| | 2018 | 2016 | TYMORA ANALYTICAL OPERATIONS, LLC | 3495 KENT AVE STE E400 | WEST LAFAYETTE | IN | 47906-1074 | TIPPECANOE | USA | R44CA200040 | Multiplexed detection and imaging of protein phosphorylation based on soluble nanopolymers | 000 | 3 | NIH | 7/13/2018 | $0 |
| | 2018 | 2016 | TYMORA ANALYTICAL OPERATIONS, LLC | 3495 KENT AVE STE E400 | WEST LAFAYETTE | IN | 47906-1074 | TIPPECANOE | USA | R41CA210772 | Developing novel RPPA for the detection of metastatic prostate cancer | 000 | 1 | NIH | 8/31/2018 | $0 |
|
| Issue Date FY: 2017 ( Subtotal = $0 ) |
| | 2017 | 2015 | TYMORA ANALYTICAL OPERATIONS, LLC | 3495 KENT AVE STE E400 | WEST LAFAYETTE | IN | 47906-1074 | TIPPECANOE | USA | R41GM109626 | Metal ion-functionalized soluble nanopolymers: A new analytical platform for plas | 000 | 2 | NIH | 9/26/2017 | $0 |
| | 2017 | 2015 | TYMORA ANALYTICAL OPERATIONS, LLC | 3495 KENT AVE STE E400 | WEST LAFAYETTE | IN | 47906-1074 | TIPPECANOE | USA | R43GM116373 | Developing gel-based platform for quantitative phosphoproteomics | 000 | 1 | NIH | 6/5/2017 | $0 |
|
| Issue Date FY: 2016 ( Subtotal = $670,595 ) |
| | 2016 | 2016 | TYMORA ANALYTICAL OPERATIONS LLC | 1281 WIN HENTSCHEL BOULEVARD | WEST LAFAYETTE | IN | 47906 | TIPPECANOE | USA | R44CA200040 | Multiplexed detection and imaging of protein phosphorylation based on soluble nanopolymers | 000 | 3 | NIH | 7/25/2016 | $445,595 |
| | 2016 | 2016 | TYMORA ANALYTICAL OPERATIONS LLC | 1281 WIN HENTSCHEL BOULEVARD | WEST LAFAYETTE | IN | 47906 | TIPPECANOE | USA | R41CA210772 | Developing novel RPPA for the detection of metastatic prostate cancer | 000 | 1 | NIH | 8/31/2016 | $225,000 |
|
| Issue Date FY: 2015 ( Subtotal = $929,987 ) |
| | 2015 | 2015 | TYMORA ANALYTICAL OPERATIONS LLC | 1281 WIN HENTSCHEL BOULEVARD | WEST LAFAYETTE | IN | 47906 | TIPPECANOE | USA | R43GM116373 | Developing gel-based platform for quantitative phosphoproteomics | 000 | 1 | NIH | 8/25/2015 | $150,000 |
| | 2015 | 2015 | TYMORA ANALYTICAL OPERATIONS LLC | 1281 WIN HENTSCHEL BOULEVARD | WEST LAFAYETTE | IN | 47906 | TIPPECANOE | USA | R41GM109626 | Metal ion-functionalized soluble nanopolymers: A new analytical platform for plas | 000 | 2 | NIH | 8/7/2015 | $328,449 |
| | 2015 | 2015 | TYMORA ANALYTICAL OPERATIONS LLC | 1281 WIN HENTSCHEL BOULEVARD | WEST LAFAYETTE | IN | 47906 | TIPPECANOE | USA | R44CA200040 | Multiplexed detection and imaging of protein phosphorylation based on soluble nanopolymers | 000 | 2 | NIH | 7/1/2015 | $451,538 |
|
| Issue Date FY: 2014 ( Subtotal = $312,537 ) |
| | 2014 | 2014 | TYMORA ANALYTICAL OPERATIONS LLC | 1281 WIN HENTSCHEL BOULEVARD | WEST LAFAYETTE | IN | 47906 | TIPPECANOE | USA | R41GM109626 | Metal ion-functionalized soluble nanopolymers: A new analytical platform for plas | 000 | 1 | NIH | 9/23/2014 | $312,537 |
|
| Issue Date FY: 2013 ( Subtotal = $444,117 ) |
| | 2013 | 2013 | TYMORA ANALYTICAL OPERATIONS LLC | 1281 WIN HENTSCHEL BOULEVARD | WEST LAFAYETTE | IN | 47906 | TIPPECANOE | USA | R43CA162767 | NOVEL SOLUBLE NANOPOLYMERS FOR ENRICHMENT OF LOW ABUNDANT PHOSPHOPROTEINS | 000 | 2 | NIH | 8/19/2013 | $144,150 |
| | 2013 | 2013 | TYMORA ANALYTICAL OPERATIONS LLC | 1281 WIN HENTSCHEL BOULEVARD | WEST LAFAYETTE | IN | 47906 | TIPPECANOE | USA | R41GM105063 | PROTEOMIC DIFFERENTIATION OF LEUKEMIA CELLS BASED ON MULTIPLEXED ARRAYS AND MASS | 000 | 1 | NIH | 9/16/2013 | $299,967 |
|
| Issue Date FY: 2012 ( Subtotal = $297,515 ) |
| | 2012 | 2012 | TYMORA ANALYTICAL OPERATIONS LLC | 1281 WIN HENTSCHEL BOULEVARD | WEST LAFAYETTE | IN | 47906 | TIPPECANOE | USA | R43EB015809 | MULTIPLEXED DETECTION AND IMAGING OF PROTEIN PHOSPHORYLATION BASED ON SOLUBLE NAN | 000 | 1 | NIH | 8/3/2012 | $147,515 |
| | 2012 | 2012 | TYMORA ANALYTICAL OPERATIONS LLC | 1281 WIN HENTSCHEL BOULEVARD | WEST LAFAYETTE | IN | 47906 | TIPPECANOE | USA | R43CA162767 | NOVEL SOLUBLE NANOPOLYMERS FOR ENRICHMENT OF LOW ABUNDANT PHOSPHOPROTEINS | 000 | 1 | NIH | 9/17/2012 | $150,000 |
|
|
